Want to see CBIO full AI Analyst Report?
Crescent Biopharma (CBIO) Hedge Fund Trading Activity
Trend: ▲ Hedge Funds Increased Holdings by 1.2M Shares Last Quarter
Hedge Fund Holdings in CBIO
Based on the 13F filings of 488 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| Hedge Fund Manager | Star Ranking | Firm | Activity | Holding Change | Value Reported | % of Portfolio | Follow |
|---|---|---|---|---|---|---|---|
 BlackRock, Inc. | Not Ranked | Added | 998.95% | $22,891,716 | <0.01% | ||
 Stephen A. Schwarzman | Blackstone Inc. | New | 100.00% | $1,127,646 | <0.01% | ||
| Michael Rockefeller | Woodline Partners LP | Added | 27.69% | $1,700,784 | <0.01% | ||
| Peter Harwin | Fairmount Funds Management Llc | Not Changed | 0.00% | $49,461,588 | 3.27% | ||
 Joseph Edelman | Perceptive Advisors LLC | Not Changed | 0.00% | $3,724,956 | 0.06% | ||
 Louis Moore Bacon | Moore Capital Management LP | Not Changed | 0.00% | $450,000 | <0.01% |
FAQ
Which hedge funds hold Crescent Biopharma?
The hedge funds that hold the most shares in Crescent Biopharma are BlackRock, Inc., Michael Rockefeller and Louis Moore Bacon.
Are hedge funds buying or selling CBIO?
In the last quarter hedge funds have Increased their holdings in Crescent Biopharma by 1.2M shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Crescent Biopharma stock?
Warren Buffet currently does not own shares in Crescent Biopharma.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here